×
ADVERTISEMENT

decitabine

Decitabine Shines in Study of AML Patients

Patients with acute myeloid leukemia (AML) who are older and fit who get pretreated with a 10-day regimen of ...

SEPTEMBER 23, 2022

For New AML, 10-Day Decitabine-Venetoclax Combo Found Effective

Treatment with a regimen of venetoclax and 10 days of decitabine resulted in a median overall survival of 18 months ...

SEPTEMBER 28, 2020

Load more